Engineered antigen presenting cells and uses thereof
The present invention relates to engineered extra-cellular vesicle internalizing receptors that have the ability to enhance uptake, processing, and presentation to T-cells of tumor-associated antigens by an antigen-presenting cell. It further relates to vectors or antigen presenting cells expressing said receptors, composition and uses thereof for the prevention and/or treatment of a cancer.
55310688
Alternative title(s) : (de) Manipulierte antigen-präsentierende zellen und deren verwendung (fr) Cellules présentant des antigènes modifiés et leurs utilisations
TTO:6.1553
DOI | Country code | Kind code | Date issued |
IL260905 | IL | B2 | 2024-05-01 |
IL260905 | IL | B1 | 2024-01-01 |
US11591407 | US | B2 | 2023-02-28 |
JP6989523 | JP | B2 | 2022-01-05 |
AU2017216213 | AU | B2 | 2021-07-01 |
JP2019511244 | JP | A | 2019-04-25 |
US2019062450 | US | A1 | 2019-02-28 |
MX2018009312 | MX | A | 2019-01-28 |
EP3411394 | EP | A1 | 2018-12-12 |
CN108602873 | CN | A | 2018-09-28 |
AU2017216213 | AU | A1 | 2018-09-20 |
IL260905 | IL | A | 2018-09-20 |
KR20180104146 | KR | A | 2018-09-19 |
SG11201806538W | SG | A | 2018-08-30 |
CA3012574 | CA | A1 | 2017-08-10 |
WO2017134100 | WO | A1 | 2017-08-10 |
EP3202783 | EP | A1 | 2017-08-09 |